Safety Study of PRLX 93936 in Patients With Advanced Solid Tumors
Clinical trial NCT00528047 · COMPLETED
Trial details
- NCT number
- NCT00528047
- Sponsor
- Prolexys Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2011-03-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.